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Abstract 35 
Protein N-terminal acetylation is a co- and post-translational modification, conserved 36 
among eukaryotes. It determines the functional fate of many proteins including their 37 
stability, complex formation and subcellular localization. N-terminal 38 
acetyltransferases (NATs) transfer an acetyl group to the N-termini of proteins, and 39 
the major NATs in yeast and humans are NatA, NatB and NatC. In this study, we 40 
characterized the Trypanosoma cruzi (T. cruzi) NatC and NatA protein complexes, 41 
each consisting of one catalytic subunit and predicted auxiliary subunits. The proteins 42 
were found to be expressed in the three main life cycle stages of the parasite, formed  43 
stable complexes in vivo, and partially co-sedimented with the ribosome in agreement 44 
with a co-translational function. An in vitro acetylation assay clearly demonstrated 45 
that the acetylated substrates of the NatC catalytic subunit from T. cruzi were similar 46 
to those of yeast and human NatC, suggesting evolutionary conservation of function. 47 
An RNAi knockdown of the Trypanosome brucei (T. brucei) NatC catalytic subunit 48 
indicated that reduced NatC-mediated N-terminal acetylation of target proteins reduce 49 
parasite growth.  50 
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1. Introduction 51 
Trypanosomes are protozoan parasites that can cause severe health problems, mainly 52 
in developing countries. Trypanosoma cruzi is the causative agent of Chagas disease, 53 
common throughout Latin America; while T. brucei, mainly present in Africa, causes 54 
sleeping sickness in humans and Nagana in livestock (1) (2). There is no vaccine 55 
against trypanosome-related diseases and the available drugs cause serious side 56 
effects (3)(4). The study about N-terminal acetylation as a possible chemotherapeutic 57 
target to fight parasite infections is limited. Protein Nα-acetylation (Nt-acetylation) is 58 
an irreversible protein modification where the acetyl moiety is transferred to the Nα 59 
amino group of a protein or polypeptide by N-terminal acetyltransferases (NATs). 60 
NATs are grouped according to their substrate specificity. In humans, seven NATs 61 
have been identified so far (NatA-F, and NatH) (5)(6). Of these, NatA, NatB and 62 
NatC have the largest number of substrates and have been characterized extensively. 63 
The human NatA protein complex is composed of a catalytic subunit (hNaa10) and an 64 
auxiliary subunit (hNaa15) and the human NatC consists of a catalytic (hNaa30) 65 
subunit and two auxiliary (hNaa35 and hNaa38) subunits (7)(8).  The proteins form 66 
stable complexes in vivo and co-sediment with the ribosome (9)(8). Of late, studies 67 
exploring the biological significance of NATs have become topical, in particular with 68 
regard to how they contribute to cellular integrity and their roles in cancer (10)(11). 69 
At the substrate protein level, Nt-acetylation may act as a degradation signal (12), 70 
mediate protein complex formation (13) or inhibit post- translational ER-translocation 71 
(14). Indeed, both human NatC and NatA have been suggested as possible target to 72 
control cancer (8)(15).   73 
N-terminal acetyltransferases (NATs); the co- and post-translational modification is 74 
common in all kingdoms of life. About 60 %, 90 %, 75 %, and 18 % of yeast, human, 75 
plant and archea proteins, respectively, are thought to be Nt-acetylated (16)(17)(5).  76 
The NatA complex from T. brucei has been found to be essential for cell viability in 77 
both the mammalian and insect stages (18). We previously characterized a novel 78 
acetyltransferase, the catalytic subunit of the NatC complex in T. cruzi (19), thought 79 
to belong to the NatC subgroup. In the present study, we have characterized and 80 
begun to investigate the biological significance of the predicted NatC and NatA in T. 81 
cruzi. 82 
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We demonstrate that the catalytic subunits (TcNaa10) and (TcNaa30), and the 83 
predicted auxiliary subunits are expressed and co-sediment with the ribosome. We 84 
find that TcNaa30 catalyzes the acetylation of N-termini similar to those acetylated by 85 
NatC in yeast (yNaa30) and hNaa30 in vitro and our analyses indicate that the protein 86 
may function both as a Nα- and as a Nε- acetyltransferase. Finally, there is an 87 
indication that the knockdown of the T. brucei NatC catalytic subunit is important to 88 
the parasite.  89 
2. Materials and Methods.   90 
 2.1 Cell culture. 91 
T. cruzi CL Brener epimastigotes were cultured as previously described (19). Tissue 92 
culture derived trypomastigotes were obtained through infection of a Vero cell 93 
monolayer, harvesting the media by centrifugation at 1640 g for 10 min. Amastigotes 94 
were obtained by harvesting 5 x 106 trypomastigotes per ml and incubating in serum-95 
free DMEM for 48 h at 37 °C. Metacyclogenesis was induced by separating 5 x 106 96 
epimastigotes per ml into Grace’s insect medium supplemented by intestinal 97 
homogenate from Rhodnius prolixus (20) and 0.5 % pyruvate-glutamate-antibiotic 98 
(PGAB). T. brucei strains were grown in HM-I9 medium at 37 °C, 5 % CO2. 99 
2.2 Identification, cloning and expression of suspected TcNatC and TcNatA subunits. 100 
Human Mak3 (hNaa30), gene ID 122830 and hNaa38 (NP_001317040.1 101 
GI:1052793474) sequences were BLASTed against the T. cruzi CL Brener proteome 102 
in order to identify T. cruzi homologs of NatC catalytic and an auxiliary subunit. 103 
Similarly, the second TcNatC auxiliary subunit was identified using plant Mak10 104 
acetyltransferase Arabidopsis thaliana) NP_001118295.1, GI:186500070 or Rattus 105 
norvegicus NP_579858.1 GI:19033372. The auxiliary subunits were amplified from 106 
total genomic DNA from Sylvio strain (TcI) using the following primers TcNATC 107 
mak10 Forward: 5' CGAATTCATGGCGTGTGACCTTGA 3', and TcNATC mak10 108 
Reverse: 5' GAGCGGCCGCTTACCTGGCTTCCTTCTTG 3', with EcoR1 and 109 
Not1 restriction sites (underlined), respectively. And, TcLsmd1 Forward: 5' 110 
GGAATTCATGGGCCGCGAGAGCATGCTTCACAA 3' and TcLsmd1 Reverse: 5' 111 
AAGCTCGAGTTAGCGCTTCCGCTT 3', with EcoR1 and XhoI restriction sites 112 
(underlined). The genes were cloned into pGEX5-1 vector expressing GST 113 
(glutathione S-transferase) and recombinant proteins were produced. The pelleted 114 
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bacteria was dissolved in PBS containing EDTA-free protease inhibitor tablets 115 
(Roche), 1 mM EDTA, 100 μg lysozyme and incubated on ice for about 15 min. 116 
Sarkosyl was added to a concentration of 1.5 %. The cells were briefly sonicated four 117 
times, 10 s each, with 30 s pauses using Branson sonifier cell disruptor B 15. The 118 
pellet and supernatant were analyzed to detect the presence of the induced protein. 119 
For the TcNatA subunits, human or yeast NatA sequences were used as queries in the 120 
NCBI BLAST database in order to identify TcNatA homologues. T. cruzi gene 121 
TcCLB.506227.230 (predicted catalytic subunit, which we named TcNaa10) and gene 122 
TcCLB.510301.80 (predicted auxiliary subunit, named TcNaa15) were identified. The 123 
genes were amplified from genomic DNA using the following primers: TcNAA10 124 
Forward: 5' AAGAATTCATGCAGATCCGTCGC 3', TcNAA10 Reverse: 125 
5'AAACTCGAGTCACTTTTTCGTCTTGCC 3', TcNAA15 Forward: 126 
5'ATCGGAATTCCGGTAGTGCTTCCTCCGGCG 3', and TcNAA15 Reverse: 5' 127 
ATCGCTCGAGGCGCTGGCCAACACCTCATCA 3'. Bold and underlined are 128 
EcoRI (forward) and XhoI (reverse) restriction sites. 129 
The genes were subsequently cloned into the pGEX5-1 vector expressing GST 130 
(glutathione S-transferase) yielding pGEX5-1-TcNaa10 and pGEX5-1-TcNaa15. The 131 
reading frames were confirmed as described previously (19). Bacterial Top10 cells 132 
(Invitrogen) transformed with pGEX5-1-TcNaa10, were grown at 37 °C until 133 
approximately OD600 0.5 and induced with 0.3 mM isopropyl β-D-1-134 
thiogalactopyranoside (IPTG). Cells were grown and processed as described before 135 
(19), except that protease inhibitor (EDTA-free tablet inhibitor from Roche) was used. 136 
The bacterial Top10 cells (Invitrogen) transformed with pGEX5-1-TcNaa15, were 137 
grown to approximately OD600 0.8 and induced with 0.1 mM IPTG at 24 °C
 
for 138 
about 24 h, and further processed as was done for pGEX5-1-TcNaa10. 139 
2.3 Generation of anti-TcNaa10, TcNaa15 and anti-TcNaa38 antibodies and western 140 
blot analysis. 141 
The antibody production for TcNaa10 and TcNaa38 was performed in a rabbit by 142 
Innovagen (Lund, Sweden), as before (19). Protein G was used to purify the IgGs. 143 
The anti-GST antibodies were removed by passing the immunoglobulin through a 144 
GST-column. The depletion and titer were evaluated by immunoblotting to GST and 145 
GST-TcNaa38, GST-TcNaa10 electrotransferred strips (not shown). Antibody against 146 
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TcNaa15 was generated by the Agrisera company (Umeå-Sweden) by inoculating one 147 
rabbit with synthetic peptides: Naa15-EL (700-712) (NH2-) CDEVLASAWEKIKE (-148 
COO). The peptide sequence was selected from conserved regions from both CL 149 
Brener haplotypes (non- Esmeraldo and Esmeraldo like). Western blotting was 150 
performed using standard procedures and as before (19). The anti-TcNaa10, anti-151 
TcNaa15 and anti-TcNaa38 antibodies were used at a dilution of 1:4000, 1:2000 and 152 
1:2000, respectively. For comparison between life cycle stages, fractions containing 153 
106 cells was lysed directly in sample loading buffer and separated on a 15 % 154 
acrylamide gel. Proteins were transferred using a semi-dry system and the membrane 155 
probed with for example, anti-TcNaa38 overnight. 156 
 2.4 In vitro acetylation assay. 157 
E. coli cells harboring the expression plasmid pGEX5-TcNaa30 were grown at 37 °C 158 
in Luria-Bertani medium containing appropriate amounts of ampicillin. Expression 159 
was induced at approximately 0.5 OD600 by the addition of 0.3 mM IPTG and 160 
growth was continued for additional 18 h at 17 oC, 190 rpm. The cells were processed 161 
as described previously (19). 162 
The enzyme activity of purified GST-TcNaa30 was determined as described in (8). In 163 
brief, GST-TcNaa30 was mixed with potential oligopeptide substrates (300 mM) and 164 
acetyl-CoA (300 mM) in a total volume of 60 μl acetylation buffers. The samples 165 
were incubated at 37 °C for 30 min. The enzyme activity was quenched by adding 5 166 
μl of 10 % TFA. The amount of acetylated oligopeptides was determined based on the 167 
absorbance at 215 nm after analysis with RP-HPLC. Synthetic Peptide Sequences 168 
used were as described elsewhere (8) (7).  169 
To assess the TcNaa10 acetyltransferase activity, recombinant protein was expressed 170 
as described above, except that growth was continued for another 25 h at 17 °C, 189 171 
rpm. The cells were chilled on ice and harvested by centrifugation at 5000 rpm for 172 
15 min. The cell pellet was suspended in 5 ml of ice-cold PBS containing EDTA-free 173 
tablets inhibitor (Roche). Cells were sonicated 4 times, 10 s each using a Branson 174 
sonifer cell disruptor B 15. Five ml of cold PBS + inhibitor, 0.5 ml of 20 % Triton X-175 
100 (final conc. 1 %) was added and the cells were incubated for 30 min at 4 °C and 176 
thereafter centrifuged for 15 min at 10,000 rpm. From a 50 % slurry of glutathione-177 
Sepharose 4B (GE Healthcare), about 250 μl were added to the supernatant and the 178 
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mixture was incubated for 2-3 h at 4 °C. The beads were washed three times with cold 179 
PBS containing 1 % Triton X-100, followed by one wash with PBS. The amount of 180 
protein on the beads was estimated from Coomassie staining of SDS-PAGE gels. 181 
The purified recombinant protein (GST-TcNaa10), eluted from the beads, was 182 
incubated with Acetyl-CoA and synthetic peptides suggested to be the substrates for 183 
NatA. The activity of the enzyme was stopped after 30 min and the results analyzed 184 
by HPLC.  185 
 186 
 2.5 Immunofluorescence microscopy. 187 
Parasites were prepared for IF essentially as previously described (21), fixing in 4 % 188 
paraformaldehyde for 5 min. Cells were then blocked in 10 % goat serum and primary 189 
antibodies were used at a 1:50 dilution for 1 h. Anti-rabbit AlexaFluor488 was used to 190 
recognize the primary antibodies and cells were DAPI stained prior to mounting in 191 
Fluoromount. Imaging was achieved using a Zeiss Axioplan2 microscope and 192 
Axiovision 4.7 software. 193 
2.6 Immunoprecipitation (IP). 194 
Approximately 109 parasites per ml were used for immunoprecipitation. 195 
Exponentially growing cells were lysed in lysis buffer [0.75 % CHAPS detergent, 1 196 
mM MgCl2, 1 mM EGTA, 5 mM β-mercapthoethanol, 10 mM Tris-HCL (pH 7.6), 10 197 
% glycerol and 1 mM Pefabloc (Roche)]. The sample was incubated on ice and later 198 
centrifuged. The supernatant was pre-cleared by incubation with protein A/G–agarose 199 
(Santa Cruz Biotechnology) on a roller for 1 h at 4 oC. The beads were removed by 200 
centrifugation at 1000 g for 3 min. The cell lysate was incubated with about 2 μg of 201 
anti-TcNaa10, or anti-TcNaa30 antibody. As a control, one part of the lysate was 202 
incubated with rabbit sera (pre- immune). Both samples were incubated on a roller for 203 
about 2.5 h at 4 oC before adding 30 μl of Protein A/G– agarose beads and further 204 
incubated overnight at the same temperature. The beads were collected by 205 
centrifugation as above, washed, mixed with sample buffer and boiled for 10 min. 206 
After centrifugation, the supernatant was analyzed by SDS/PAGE and western 207 
blotting. Reciprocal IP with anti-TcNaa15, or anti-TcNaa38 was done as described 208 
except that in this case, the lysate was not pre-cleared.  209 
2.7 Polysome Isolation. 210 
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Total ribosome isolation was performed using a modification of previously described 211 
methods (8). Approximately 109 cells were used per experiment. Prior to harvesting, 212 
parasites were treated with 100 μg/ml cycloheximide (CHX) for about 10 min on ice. 213 
Cells were then lysed with KCl ribosome lysis buffer (8) and incubated on ice for 15 214 
min. Cells were homogenized by repeated pipetting and the homogenate verified with 215 
light microscopy. The lysate was centrifuged at 18000 g at 4 oC for 5 min using 216 
Beckman rotor 25.50. One ml of the lysate was overlaid on 3 ml of 25 % sucrose 217 
cushion sucrose and ultra-centrifuged at 135,715.5 g for 2 h using Sorvall AH-650 218 
rotor (Beckman) .The pellet was dissolved in ribosomal lysis buffer. Total parasite 219 
lysate, top supernatant (post-polysome lysate) and ribosomal pellet were analyzed by 220 
SDS-PAGE and western blotting. 221 
2.8 Nuclear and cytoplasmic preparation. 222 
About 107 exponentially growing parasites were washed twice in PBS and lysed in 10 223 
ul of TELT buffer (50 M Tris-HCL pH 8, 62.5 mM EDTA, 2.5 M LiCl, 0.4 % Triton 224 
X-100 and 100 mg/ml lysozyme). Thereafter, NE-PER Nuclear and Cytoplasmic 225 
Extraction Reagents kit from Thermo Scientific was used according to 226 
recommendation, but with double amount of reagents. Prior to the use of the kit, the 227 
parasites were lysed by TELT, as the detergent provided with the kit did not lyse the 228 
parasite at the condition tested. Anti-cyclophilin A (kindly provided by Jacqueline 229 
Bủa, Instituto Nacionale de Parasitologia, Buenos Aires, Argentina) and anti- histone 230 
3 from Upstate (Millipore) were used as positive control for cytoplasmic and nuclear 231 
proteins, respectively. 232 
2.9 Bioinformatics. 233 
Homology searches were performed using the NCBI BLAST server. Extracted protein 234 
sequences were aligned using Clustal Omega multiple sequence alignment tool. 235 
ScanProsite and InterPro Protein sequence analysis and classification tools were used 236 
to identify domains. 237 
2.10 Generation of predicted T. brucei NatC catalytic subunit (TbNaa30) RNAi cell 238 
lines. 239 
The putative protein-coding region comprising nucleotides (216-788) of the predicted 240 
TbNaa30 (Tb927.7.2360), that is, a 573 bp fragment, was PCR-amplified using 241 
forward primer TbNatC- Naa30RNAi: 242 
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5 ́ATCGGGATCCCTACGGATGTCGCTCCTAGC 3 ́ and reverse primer TbNatC- 243 
Naa30RNAi: 5 ́ ATCGAAGCTTGTAGCGCGGCAGAAATTTAG 3 ́. Underlined 244 
are BamHI and Hind III restriction sites, respectively. The PCR product was sub 245 
cloned into tetracycline- inducible RNAi vector p2T7-177 using the restriction sites to 246 
yield p2T7-TbNaa30. The presence of the insert was verified by digesting the plasmid 247 
with respective enzymes. For easy incorporation into the chromosome, resulting 248 
plasmid (about 10 μg) was linearized with NotI and transfected into T. brucei brucei 249 
427 strain by electroporation, using about 2 x 107 cells. Non-linearized plasmid and 250 
mock transfection were used as negative controls. The transformants were selected 251 
with phleomycin (2.5 μg). To confirm if the transfection was successful, DNA was 252 
extracted from the surviving parasites and PCR was performed to amplify the 253 
phleomycin gene fragment (350 bp) using specific primers (Phleo Forward 5’ ATG 254 
GCC AAG TTG ACC AGT GCC 3’ and Phleo Reverse 5’ TGC ACG CAG TTG 255 
CCG GCC GGG 3’). The starting parasite density of 2.5 x 104 /ml was used and 256 
RNAi was induced using 100 ng of tetracycline. The same parasite density was used 257 
for the transformants and wild type (T. b. brucei 427). The non-induced/wild type and 258 
induced cells were examined and counted daily using light microscopy. Samples for 259 
gene/protein expression analyses were harvested daily for five days. 260 
3. Results 261 
3.1 Identification and sequence analysis of TcNat proteins. 262 
The catalytic subunit of the TcNatC complex was identified by blast analysis and as 263 
previously described (19) (table 1). In accordance with the recommended 264 
nomenclature (22), we now refer to this gene as TcNaa30. Similarly, we identified 265 
putative genes for the T. cruzi homologues of NatC auxiliary subunits (TcNaa35 and 266 
TcNaa38), (table 1). The gene showed 19 %, 22 %, 49 % and 62 % sequence identity 267 
at the aa level to its rat, plant, Leishmania major and T. brucei counterpart, 268 
respectively. For TcNaa38, gene Tc00.1047053507209.10 (Tc9.10) was identified as 269 
the likely TcNatC subunit, (table 1). At the aa level, the TcNaa38 gene shares, 32 %, 270 
38 %, 57 % and 62 % sequence identity with its yeast, human, Leishmania major and 271 
T. brucei counterpart, respectively.  272 
T. cruzi NatA homologs were identified by comparing with human Naa10, (gene ID 273 
728880) (table 1). The T. cruzi gene TcCLB.506227.230 (Tc7.230) was found to 274 
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share 60 % and 42 % identity at the amino acid (aa) level with the human and yeast 275 
genes, respectively. We now refer to this gene as TcNaa10 according to the latest 276 
nomenclature (22). In a search to identify the T. cruzi NatA auxiliary subunit, we used 277 
hNaa15 (NP_476516.1), as a BLAST query sequence. As seen in (table 1), the search 278 
identified CL Brener gene TcCLB.504163.110 (Tc3.110) and TcCLB.510301.80 279 
(Tc01.80), with 29 % and 28 % sequence identity at the aa level, respectively. Both 280 
alleles were annotated as putative N-acetyltransferase subunit Nat1 and named 281 
TcNaa15. Sequence comparison of predicted TcNaa35, TcNaa38, TcNaa10 and 282 
TcNaa15 with selected species is displayed in (Supplementary Fig. S1). 283 
 3.2 Expression and recombinant production of TcNatA and TcNatC protein subunits. 284 
We previously expressed the putative TcNaa30 and showed that it has auto-285 
acetylation enzyme activity (19). To further characterize the TcNatC and TcNatA 286 
protein complex, we cloned the TcNaa35 and TcNaa38 ORFs and produced 287 
recombinant protein. (Supplementary Fig. S2A and S2B) show the recombinant 288 
protein (GST- TcNaa35 and GST-TcNaa38) with an expected size of about 110 and 289 
40 kDa, respectively. The annotated proteins of TcNaa10 and TcNaa15 have 290 
predicted molecular weights of 29.4 and 82.9 kDa, respectively, and we again 291 
produced recombinant proteins. TcNaa10 was initially insoluble (Supplementary Fig. 292 
S2C and S2D) and was dissolved in sarkosyl as described previously (25).  293 
 3.3 Expression of TcNaa38/TcNaa30 and TcNaa10/TcNaa15 in the parasite. 294 
To investigate the expression pattern of TcNatC and TcNatA, we used western blot to 295 
detect the proteins in the different stages of the parasite life cycle. In the study, 296 
polyclonal antibodies were produced in rabbit against the whole protein. The antibody 297 
against TcNaa15 was generated in a rabbit using synthetic peptides. But, inoculating 298 
one rabbit with synthetic peptides generated antibody against TcNaa15. For all the 299 
proteins assessed, we first carried out western bot analysis for pre-immune rabbit sera, 300 
and as expected, no band /signal was detected (not shown).  301 
Analysis showed that TcNaa38 was expressed in the three main stages, i.e. in the 302 
epimastigote, trypomastigote and amastigote stages of T. cruzi CL Brener (Figure 303 
1(A)). However, multiple bands of similar size were recognized in all the stages, 304 
possibly due to post- translational processing of proteins. the hybrid nature of CL 305 
Brener strain. The identity of the extra bands has not been investigated in this study. 306 
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Anti-TcNaa38 and anti-TcNaa30 also recognized, for example GVR35 (26) and 307 
URTO (27) strains of T. brucei proteins (Figure 1(B)). TcNaa10/TcNaa15 were also 308 
found to be expressed in epimastigote, trypomastigote and amastigote stages of the T. 309 
cruzi CL Brener strain (Figure 1(C)). But, except for amastigote, extra bands could be 310 
seen for aAnti-TcNaa15 detected additional bands in all developmental stages, except 311 
amastigotes. The identities of these bands are not known. Furthermore, the result 312 
suggests an up-regulation of TcNaa15 in the trypomastigote and amastigote stages 313 
with an opposite effect seen for TcNaa10, that is, down-regulated in trypomastigotes 314 
and amastigotes (Figure 1(C)). As displayed in (Figure 1(D)), anti-TcNaa10 was 315 
found to cross react with T. brucei, while anti-TcNaa15, as expected, did not. because 316 
specific peptide sequence was selected from CL Brener haplotypes to generate the 317 
antibody used in the experiment. In contrast to T. cruzi, anti-TcNaa10 recognized an 318 
extra band of 17 kDa in T. brucei, with no known identity. Taken together, the results 319 
indicate that the TcNatA and TcNatC protein complexes are constitutively expressed 320 
in T. cruzi. 321 
 322 
3.4 Localization of TcNaa30 and TcNaa10/TcNaa15 by fractionation.  323 
The staining profile of the putative TcNaa30 was previously shown to be 324 
predominantly located in the cytoplasm As shown in (19), the staining profile  of the 325 
putative TcNaa30 was predominantly located in the cytoplasm, and we now observed 326 
the same result by fractionation (Figure 2(A)). For TcNaa15 and TcNaa10, both 327 
proteins showed nuclear and cytoplasmic location (Figure 2(B)).  328 
3.5 Subcellular localization of TcNaa30 /TcNaa38 and TcNaa10/TcNaa15 by 329 
immunofluorescence. 330 
In assessing all the staining patterns assessed for of the four proteins, not that, no 331 
staining was observed by pre-immune sera, or by secondary antibody alone (data not 332 
shown). In both midlog and stationary epimastigotes, the TcNaa30 exhibited some 333 
perinuclear accumulation and punctate structures could be observed, particularly in 334 
the stationary phase (Figure 3(A)). In both metacyclic and tissue culture derived 335 
trypomastigotes, TcNaa30 appeared to be relatively sequestered in a perinuclear 336 
distribution, as was observed in (28). When trypomastigotes were differentiated into 337 
amastigotes in vitro, however, more peripheral staining was observed (Figure 3(A)). 338 
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These differences could possibly be related to differential regulation of protein 339 
trafficking. 340 
TcNaa38 staining was predominantly punctate and cytoplasmic labeling more diffuse 341 
at the midlog stages (Supplementary Fig. S3A). Tissue culture derived 342 
trypomastigotes showed a diffuse cytoplasmic localization with some perinuclear 343 
accumulation. In amastigotes in vitro, TcNaa38 staining was again punctate and 344 
cytoplasmic (Supplementary Fig. S3A). Using a Vero cell monolayer to assess 345 
intracellular amastigotes, the staining profile showed a diffuse localization of 346 
TcNaa30 in the cytoplasm, and a more punctuated labeling for TcNaa38 347 
(Supplementary Fig. S4). 348 
The localization pattern of TcNaa10 and TcNaa15 in vivo in the four developmental 349 
stages of the parasite were assessed. TcNaa10 was mainly seen around the nucleus in 350 
midlog and stationary epimastigotes (Figure 3(B)). In trypomastigotes, TcNaa10 351 
appeared exclusively around the nucleus (Figure 3(B)). The staining profile of 352 
TcNaa10 in amastigotes meanwhile, was restricted to the periphery of the cell (Figure 353 
3(B)). In all the life cycle stages, TcNaa15 appeared to predominantly localize to the 354 
cell periphery (Supplementary Fig. S3B). The cytoplasmic labeling disappeared in the 355 
metacyclic stages as TcNaa15 localized to the kinetoplast (Supplementary Fig. S3B). 356 
Tissue culture trypomastigotes exhibited a more diffuse cytoplasmic localization and 357 
expression was reduced to a structure resembling the remaining short flagellum in 358 
amastigotes (Supplementary Fig. S3B). 359 
3.7 TcNaa30/TcNaa38 and TcNaa10/TcNaa15 co-sediment with the ribosome.  360 
We examined the TcNaC co-sedimentation with the ribosome through a sucrose 361 
cushion, and as shown in (Figure 4(A)), TcNaa30 is present in both the ribosomal and 362 
non-ribosomal fractions. A smaller amount of TcNaa38 could also be observed in the 363 
polysome fraction. The results for TcNatA (Figure 4(B)) showed the presence of 364 
TcNaa10 and TcNaa15 in both the ribosomal and non-ribosomal fractions. Anti-365 
TcNaa15 detected an additional band of approximately 54 kDa in the ribosomal 366 
fraction. In contrast, anti- TcNaa10 detected a band of about the same size in the non-367 
polysome fraction. The identity of the extra band is not known. Taken together, 368 
the ribosomal co-sedimentation results indicated that the TcNatA and TcNatC 369 
proteins might associate with the ribosomes. 370 
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 3.8 T. cruzi NatC and TcNatA subunits interact in vivo and in vitro. 371 
Human orthologs of TcNaa30, TcNaa35 and TcNaa38 form a stable complex in vivo 372 
(8). To investigate whether TcNaa30 and TcNaa38 formed a stable complex in T. 373 
cruzi, immunoprecipitation using anti TcNaa30 and anti TcNaa38 was performed. 374 
Immunoprecipitation with anti-TcNaa30 was unsuccessful, but using anti-TcNaa38 375 
we were able to immunoprecipitate TcNaa30 (Figure 5(A)). Though further study is 376 
required, this indicates that these proteins physically interact in T. cruzi, either 377 
directly or through another protein, for example, the ribosome complex. Likewise, 378 
immunoprecipitation showed that anti-TcNaa10 was able to immunoprecipitate 379 
TcNaa15 (Figure 5(B)) upper panel. By reciprocal immunoprecipitation, anti-380 
TcNaa15 was able to pull down TcNaa10, (Figure 5(B)) lower panel. This analysis 381 
suggests that the TcNaa10 and TcNaa15 interact in vivo in the same way as yeast and 382 
human orthologs of the TcNaa10 and TcNaa15 form a stable complex in vitro and in 383 
vivo (7)(9)(29).                                              384 
 3.9 In vitro Nα-acetyltransferase assay. 385 
In order to investigate the substrate specificity of TcNatC and TcNatA, we performed 386 
an in vitro Nt-acetylation assay where purified recombinant protein (GST-TcNaa30) 387 
was incubated with synthetic peptides representing substrates for different classes of 388 
NATs (NatA-NatE). As shown in (Figure 6), TcNaa30 preferentially acetylates a 389 
peptide with a hydrophobic N-terminal sequence of MLGP, which corresponds to a 390 
typical NatC/E/F substrate in humans. We also attempted to assess TcNaa10 391 
enzymatic activity, and whether the TcNaa10 substrate preferences are identical to 392 
those in human cells in a similar way as above. Though there was an indication of 393 
Naa10 activity, preferentially acetylating the synthetic peptide sequences STPD and 394 
EEEIA (not shown), representing human NatA substrates, no reproducible activity 395 
was found.  396 
  397 
3.10 Effect of knock down of predicted T. brucei NatC catalytic subunit by RNAi. 398 
RNAi was carried out on the T. brucei equivalent of the TcNaa30 gene. RNAi was 399 
induced in Trypanosoma brucei brucei 427 using tetracycline. For the wild type, 400 
tetracycline had no effect on their viability (Supplementary Fig. S5A).  401 
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For the transfectants, significantly reduced growth was observed in both the induced 402 
and non-induced after 48h and 72h.  403 
We observed a significant a reduction in parasite growth in both the induced and non-404 
induced after 48 h and 72 h (not shown Supplementary Fig. S5B and S5C). This 405 
indicated that the RNAi vector was leaky. An RT-PCR assay (not shown 406 
Supplementary Fig. S5D) indicated that at 48 h post induction, there was a decrease in 407 
the levels of endogenous mRNA in the induced and non-induced trans-formant cell 408 
compared to the wild type. Western blotting using anti- T.  cruzi NatC (TcNaa30) 409 
showed that, especially after 48 h, there was lower protein expression in the non-410 
induced and induced cells compared to the wild type (Fig. 7).  411 
 412 
4. Discussion 413 
 We here describe the molecular cloning and characterization of the predicted T. cruzi 414 
NatC and T. cruzi NatA Nα -acetyltransferase protein complexes. We found that 415 
protein Nt-acetylation by T. cruzi NatC and NatA was similar to what has been 416 
described in other eukaryotes. It appears that the expression profile of TcNatA and 417 
TcNatC in different parasite life cycle is not uniform. But, how this translates to the 418 
distinct parasite morphologies and biology is not clear. Similar to expression, the 419 
localization profile of TcNatC and TcNatA proteins by immunofluorescence in the 420 
different life cycle forms are diverged. The functional significance of these, are 421 
speculated. Similar staining patterns were observed (16)(30)(31) for human 422 
Naa40/NatD and other NATs proteins. Given the divergent expression and 423 
localization of the TcNatC and TcNatA proteins, it is tempting to speculate that, the 424 
given protein is located at a particular compartment at a given time to carry biological 425 
tasks. Considering localization of T. brucei (Tb927.7.2360) a similar gene to TcNaa30 426 
by GFP-tagged version (32), the T. brucei gene N-terminally and C-terminally tagged 427 
versions are distributed throughout the cell. Localization of TcNaa30 in our hands is 428 
predominantly distributed in the cytoplasm, suggesting differential biological function 429 
in trypanosomes. Further analyses are needed to confirm this hypothesis. 430 
TcNatC and TcNatA proteins physically interact with each other and it is plausible 431 
that this interaction takes place in the cytoplasm as suggested by their possible 432 
ribosomal co-sedimentation. Possibly, the proteins in some cases carry out their 433 
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function independently of each other as suggested in other organisms (16), and that 434 
they may have specific functions depending on the parasite life cycle stage. 435 
TcNatC/TcNatA proteins may also have other functions independent of the NAT-436 
activity as suggested in other species (15).  437 
The biological significance of post-translational modification of proteins, especially 438 
acetylation, in trypanosomes is relatively unexplored (33). We predicted the TcNatC 439 
substrates profile and detected many parasite-specific proteins that lack homologues 440 
in humans (Table 2). For TcNatA substrates, the predictions include hypothetical 441 
proteins, as well as mucin-associated surface protein (MASP) and mucin proteins (not 442 
shown). The MASP gene family is preferentially expressed in the trypomastigote 443 
(34). Moreover, it is exposed to the host immune system and possibly used by the 444 
parasite during infection (34). Another noticeable predicted T. cruzi NatC and 445 
TcNatA substrate is trans-sialidase (TS); a polymorphic surface enzyme used by the 446 
parasite during infection (35). Taken together, it can be speculated that Nt-acetylation, 447 
if lost, could simultaneously affect many surface antigens including TS, or many 448 
parasite-specific functions and cellular processes that are important for pathology.  449 
 For the extracellular parasite T. brucei, some proteins used by the parasite to evade 450 
the host immune system were predicted as possible substrates for TbNatC (not 451 
shown). These include receptor-like adenylate cyclases (36), variant surface 452 
glycoprotein and an expression site- associated gene (37). Study of the N-terminal 453 
acetylome by proteomic methods in trypanosomes (33) confirms our prediction that, 454 
Nt-acetylation state in these organisms is common. Further studies are required for a 455 
complete understanding of which cellular machineries are regulated this way and how 456 
this is important for the life of the parasite.  457 
In yeast, human and plants, the biological significance of NatC knockdown has been 458 
investigated (38)(8)(39). These studies point towards loss of cell viability if NatC is 459 
depleted. The NatA protein complex was found to be essential for cell survival in T. 460 
brucei (18). Given the sequence identity, and the similar predicted ligand binding and 461 
active sites, it is likely that NatA is essential in all trypanosomatids. In this study, 462 
silencing of the T. brucei NatC predicted catalytic subunit by RNAi suggests that the 463 
protein may be important to the parasite, though there was minor reduction of the 464 
predicted protein band in the blot in the transfected cells compared with the control. 465 
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Another system for conditional knockouts for trypanosomatids such as CRISPR/Cas9 466 
could be tested to ascertain our observation in this study. Or, perform genome-scale 467 
RNAi (40) by silencing the parasites NATs catalytic subunits and phenotypes 468 
assessed. It is clear though, that, these are basic, important functions that are of 469 
interest for gene function and regulation as well as for possible drug target testing.  470 
Collectively, identification of all the NATs in T. cruzi, analyzing substrates 471 
preferences and proteomic study of Nt-acetylation in all the developmental stages will 472 
narrow the gaps in knowledge of the parasite biology.  473 
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Table 1. TcNatC and TcNatA genes. * Denote genes investigated in this study. 675 
 676 
Table 2. Some estimated number of predicted TcNaa30 substrates for CL Brener 677 
haplotypes based on Met-Leu, Met-Ile, Met-Phe and Met-Tyr N-termini. 678 
TcNat Gene CL Brener haplotype
TcNatC catalytic subunit (TcNaa30) Tc00.1047053511809.120 (Tc9.120) Non- Esmeraldo-like *
Tc00.1047053511811.30 (Tc1.30) Esmeraldo- like
TcNatC auxiliary subunit (TcNaa35) Tc00.1047053511311.80 (Tc1.80) Esmeraldo- like
Tc00.1047053511755.119 (Tc5.119) Non- Esmeraldo-like *
TcNatC auxiliary subunit (TcNaa38) Tc00.1047053507209.10 (Tc9.10) Non- Esmeraldo-like *
TCNatA catalytic subunit (TcNaa10) TcCLB.506227.230 (Tc7.230) Esmeraldo-like *
TCNatA auxiliary subunit (TcNaa15) TcCLB.504163.110 (Tc3.110) Esmeraldo-like



























Figure 1: Expression of TcNaa38/TcNaa30 and TcNaa10/TcNaa15 in trypanosomes. 703 
 A; Total proteins from different stages of T. cruzi life cycle, epimastigote midlog 704 
(M), epimastigote stationary phase (S), trypomastigote (T) and amastigote (A) were 705 
used for western blotting. B; Cross reaction of anti-TcNaa30 and anti-TcNaa38 706 
against different T. brucei strains. Tb-Gvr (T. brucei GVR strain), Tb-R17 (T. brucei 707 
R17 strain) and Tc-Brener epimaastigote (T .cruzi CL Brener strain). C; 708 
Developmental stage expression of TcNaa10 and TcNaa15 in CL Brener strain 709 
epimastigote (E), trypomastigote (T) and amastigote (A). Purified anti-TcNaa10 and 710 
anti-TcNaa15 (1:4000, and 1: 2000 dilutions) were used for western blotting. D; 711 
Cross reaction of anti-TcNaa10 (upper panel) and anti- TcNaa15 (lower panel) against 712 
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Figure 2:  Localisation of TcNaa30 and TcNaa10/TcNaa15 in T. cruzi. A; TcNaa30 722 
localization in epimastigotes by western blotting. B; Localization of 723 
TcNaa10/TcNaa15. Cytoplasmic (Cyt) and nuclear (N) fractions were assessed for the 724 
presence of TcNaa30, TcNaa10 and TcNaa15. Anti- cyclophilin A and anti-histone 3, 725 
were used as positive controls for cytoplasmic and nuclear protein, respectively. T/L 726 
indicates total cell lysate. 727 
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Figure 3: Localization of TcNaa30 and TcNaa10 by immunolabelling. Number 1 to 5 731 
denotes, Midlog epimastigotes, Stationary epimastogotes, Metacyclic 732 
trypomastigotes, Trypomastigotes, and Amastigotes, respectively. T. cruzi four life 733 
cycle stages were immunolabelled with, A; anti-TcNaa30 and B; anti-TcNaa10. The 734 












Figure 4: Association of TcNaa30 /TcNaa38 and TcNaa10/TcNaa15 with the 738 
ribosome. A; Membrane was incubated with anti TcNaa30 and anti TcNaa38. Total 739 
cell lysate (T/L), supernatant post-ultracentrifugation (P/L) and polysomes (Poly) 740 
were loaded. As controls, anti-T. cruzi S7 (specific for the ribosome) and anti- T. 741 
cruzi cyclophilin A (non-ribosomal) were used. Molecular size markers in kDa are 742 
indicated on the left. B; Membrane was incubated with anti TcNaa10 and TcNaa15. 743 
Loading control as mentioned in Fig. 4A.  744 
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Figure 5: TcNatC and TcNatA protein interaction. A; Immunoprecipitation (IP) of 746 
TcNaa30. The parasite lysate was incubated with anti-TcNaa38.  As a control, the 747 
lysate was incubated with rabbit sera (pre-immune). The blot was analyzed with anti-748 
TcNaa30. Molecular weight marker in kDa is indicated. B; Co- Immunoprecipitation 749 
assays of TcNaa10 with TcNaa15 protein. IP with pre- immune sera was used as a 750 
control. Western blots of the immunoprecipitated samples were probed with rabbit 751 
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Figure 6: In vitro acetyltransferase activity of TcNaa30. GST-TcNaa30 was 766 
incubated with acetyl-CoA (300 mM) and selected oligopeptides (300 mM) for 30 767 
min at 37 °C. dH2O was used as negative control. The amount of acetylated peptide 768 
was determined with reverse phase HPLC. Oligopeptide names indicate the first four 769 
amino acids from the N-terminus. N.D represent non- detectable. The * indicates that 770 







Figure 7: Phenotype of the knock down of putative T. brucei Naa30 by RNAi. 775 
TcNaa30 protein expression analysis of wild type (W), transformant (T), non-induced 776 
(-) and induced (+) cells by western blotting. Cells were counted, washed, dissolved 777 
in sample buffer and immediately boiled. About equal amount of each sample was 778 
used in the experiment. Note that a band of about 17 kDa, whose identity is not 779 
known, was also identified. GAPDH was used as loading control. 780 
 781 
